Skip to main content
OpenTrials

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

396 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Histiocytosis trial results

Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details
Active, Not Recruiting

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

NCT02205762

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

NCT05563844

Conditions
Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma，DLBCL, Hemic and Lymphatic Diseases, +5 more
Locations
  • Ruijin Hospital of Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH

NCT07204041

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing, Beijing, China
View Trial Details

Related conditions